Azora Therapeutics (AZR) News
NASDAQ: AZRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.85-0.02 (-0.52%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AZR news summary
We found 2 recent headlines mentioning Azora Therapeutics (AZR): 1 in the past week and 2 in the past 30 days, most often from GlobeNewswire. For price context, AZR is down 0.52% at $3.85. The most recent story, "Azora Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)", was published by GlobeNewswire on Nov 19, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Azora Therapeutics headlines
- Azora Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)LOS ANGELES, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Azora Therapeutics, Inc. (NASDAQ: AZR) (the “Company”), a biopharmaceutical company developing treatments for serious inflammatory diseases, announced…GlobeNewswire
- Azora Therapeutics Reports 2026 Third Quarter Financial Results and Provides Business UpdateAzora Therapeutics commenced trading on Nasdaq as “AZR”GlobeNewswire